美国食品和药物管理局 (FDA) 现代化法案2.0:非发展中国家的见解
Sajidur Rahman Akash1,2, M A Jobayer Billah Arnob3, Md Jamal Uddin2,4
1Department of Pharmacy, Bangladesh University, Dhaka, Bangladesh.
Drug development research
|August 17, 2023
概括
食品和药物管理局现代化法案2.0允许替代药物测试,远离动物测试. 这种转变为药物开发提供了新的可能性,特别是在不发达国家.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 生物技术是生物技术.
- 监管科学 监管科学
背景情况:
- 动物试验是药物的疗效和安全性评估的传统要求.
- 食品和药物管理局现代化法案2.0对药物开发协议进行了重大变化.
研究的目的:
- 探索食品和药物管理局现代化法案2.0.0所允许的替代药物测试方法.
- 讨论这些替代方法对不发达国家的影响.
主要方法:
- 审查包括in silico建模在内的替代测试策略.
- 检查人类组织芯片工程和组织工程.
- 分析无动物复合抗体和人工智能应用.
主要成果:
- 该法案有助于采用新的非动物试验方法.
- 替代方法对可靠的药物评估有希望.
- 可能对全球药物开发产生重大影响,特别是在资源有限的环境中.
结论:
- 食品和药物管理局现代化法案2.0为临床前药物测试的范式转变铺平了道路.
- 替代方法为药物开发提供了道德和潜在的更有效的途径.
- 解决不发达国家的需求对于公平的全球卫生进步至关重要.
相关概念视频
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Control Governance: Regulatory Bodies and Their Impact
184
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
184
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Drug Administration and Therapy Phases: Overview
532
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
532
Pharmacovigilance
889
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
889


